Cigna Investments Inc. New cut its position in Anthem, Inc. (NYSE:ANTM) by 5.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,277 shares of the company’s stock after selling 616 shares during the period. Cigna Investments Inc. New’s holdings in Anthem were worth $1,933,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently bought and sold shares of ANTM. Raymond James Trust N.A. increased its position in shares of Anthem by 16.2% in the first quarter. Raymond James Trust N.A. now owns 3,457 shares of the company’s stock worth $572,000 after buying an additional 482 shares in the last quarter. Quadrant Capital Group LLC increased its position in shares of Anthem by 5.0% in the first quarter. Quadrant Capital Group LLC now owns 1,540 shares of the company’s stock worth $245,000 after buying an additional 74 shares in the last quarter. National Pension Service increased its position in shares of Anthem by 2.4% in the first quarter. National Pension Service now owns 193,494 shares of the company’s stock worth $32,329,000 after buying an additional 4,590 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. increased its position in shares of Anthem by 11.0% in the first quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 2,725 shares of the company’s stock worth $451,000 after buying an additional 270 shares in the last quarter. Finally, Highland Capital Management LLC acquired a new position in shares of Anthem during the first quarter worth $324,000. 89.48% of the stock is currently owned by institutional investors.
Anthem, Inc. (NYSE ANTM) traded down 0.49% during midday trading on Friday, hitting $191.02. The stock had a trading volume of 1,061,167 shares. The company has a market cap of $50.16 billion, a price-to-earnings ratio of 18.06 and a beta of 0.73. The company’s 50 day moving average is $190.39 and its 200 day moving average is $177.46. Anthem, Inc. has a 1-year low of $114.85 and a 1-year high of $194.94.
Anthem (NYSE:ANTM) last issued its quarterly earnings data on Wednesday, July 26th. The company reported $3.37 earnings per share for the quarter, topping the consensus estimate of $3.23 by $0.14. Anthem had a net margin of 3.24% and a return on equity of 12.93%. The company had revenue of $22.20 billion for the quarter, compared to analysts’ expectations of $22.25 billion. During the same quarter in the previous year, the firm posted $3.33 earnings per share. Anthem’s revenue for the quarter was up 4.3% on a year-over-year basis. On average, equities analysts anticipate that Anthem, Inc. will post $11.82 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be issued a $0.70 dividend. This is a positive change from Anthem’s previous quarterly dividend of $0.65. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.80 annualized dividend and a yield of 1.47%. Anthem’s payout ratio is presently 24.62%.
COPYRIGHT VIOLATION WARNING: This report was originally published by Rincon Hill News and is the property of of Rincon Hill News. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://rinconhillneighbors.org/2017/08/19/cigna-investments-inc-new-reduces-stake-in-anthem-inc-nyseantm-updated.html.
A number of brokerages have recently weighed in on ANTM. Cantor Fitzgerald reiterated a “buy” rating and set a $136.00 price target on shares of Anthem in a report on Thursday, May 11th. Morgan Stanley initiated coverage on Anthem in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $196.00 target price on the stock. Bank of America Corporation boosted their target price on Anthem from $224.00 to $228.00 and gave the company a “buy” rating in a research note on Friday, July 14th. Deutsche Bank AG boosted their target price on Anthem from $173.00 to $185.00 and gave the company a “hold” rating in a research note on Thursday, July 13th. Finally, Citigroup Inc. reaffirmed a “buy” rating and issued a $205.00 price target on shares of Anthem in a research report on Wednesday, June 28th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $181.76.
In related news, EVP Thomas C. Zielinski sold 9,127 shares of the business’s stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $191.25, for a total value of $1,745,538.75. Following the transaction, the executive vice president now owns 26,571 shares in the company, valued at $5,081,703.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Julie A. Hill sold 555 shares of the business’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $180.56, for a total transaction of $100,210.80. Following the completion of the transaction, the director now owns 37,448 shares in the company, valued at approximately $6,761,610.88. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,754 shares of company stock worth $2,595,073. 0.36% of the stock is owned by company insiders.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with our FREE daily email newsletter.